Evidence map›Paper›PMID 35101539›Full record

ArticleInternational journal of cardiology2022

Cardiac structure and function and quality of life associations in HFpEF: An analysis from TOPCAT-Americas.

João Pedro Ferreira, Amil M Shah, Brian L Claggett, Bertram Pitt, Eldrin F Lewis, Scott D Solomon, Faiez Zannad

Abstract read
In one paragraph

Article in International journal of cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

João Pedro FerreiraUniversité de Lorraine, Inserm, Centre d'Investigations Cliniques Plurithématique 1433, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France; Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal. Electronic address: j.ferreira@chru-nancy.fr.
Amil M ShahDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Brian L ClaggettDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Bertram PittDepartment of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA.
Eldrin F LewisDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford University, Palo Alto, CA, USA.
Scott D SolomonDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Faiez ZannadUniversité de Lorraine, Inserm, Centre d'Investigations Cliniques Plurithématique 1433, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.

Funding

Mapping the Progression to HFpEF in the Elderly through Longitudinal Changes in Cardiac FunctionR01HL135008 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI Amil M Shah · 2017 to 2026
$11.5M
Mentoring patient-oriented research in deep phenotyping of cardiac function for heart failure preventionK24HL152008 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI SHAH, AMIL M · 2020 to 2024
$608k
NHLBI NIH HHS HHSN268200425207CNHLBI NIH HHS K24 HL152008NHLBI NIH HHS R01 HL135008
6 · The paper itself

Abstract

backgroundPatients with heart failure with preserved ejection fraction (HFpEF) have poor health-related quality of life (HR-QoL). However, the relationship between HR-QoL measures and the alterations of cardiac structure and function that are present in patients with HFpEF remains unknown.

aimsTo study the associations between HR-QoL and echocardiographic parameters in HFpEF.

methodsRegression modelling in patients from TOPCAT-Americas who had both HR-QoL questionnaires and a baseline echocardiogram.

resultsA total of 631 patients (36% of the TOPCAT-Americas population) had both echocardiographic and HR-QoL at baseline. KCCQ-23 Overall Summary Score (OSS; 0-100 points) was negatively (higher echocardiographic values-poorer/lower HR-QoL scores) associated with left ventricular end-diastolic diameter (LVEDD: β = -3.56 [-7.00 to -0.13] points-per-1 cm, P = 0.042), interventricular septum thickness (β = -1.31 [-2.19 to -0.42] points-per-1 mm, P = 0.004), posterior wall thickness (β = -1.57 [-2.52 to -0.63] points-per-1 mm, P = 0.001 and left atrial width (β = -3.27 [-6.39 to -0.15], P = 0.040) points-per-1 cm, and positively (higher echocardiographic values-better/higher HR-QoL scores) associated with left ventricular end-diastolic volume index (LVEDVi: β = 0.23 [0.09 to 0.37] points-per-1 ml/m2, P = 0.002) and left ventricular end-systolic volume index (LVESVi: β = 0.41 [0.18 to 0.63] points-per-1 ml/m2, P < 0.001). Body mass index (BMI: β = -0.74 [-1.02 to -0.47] points-per-1Kg/m2, P < 0.001), diabetes (β = -6.01 [-10.05 to -1.97], P = 0.004), and asthma (β = -6.78 [-13.52 to -0.04], P = 0.049) were negatively associated with OSS. A similar pattern of associations was observed for KCCQ-23 Clinical Summary Score, EQ5D-VAS and NYHA class.

conclusionIn patients with HFpEF, HR-QoL measures were associated with cardiac structure and function alterations. Extra-cardiac factors were also associated with HR-QoL, which may influence HR-QoL results when testing cardiovascular drugs.

Indexed as

Heart FailureQuality of LifeEchocardiographyHeart VentriclesHumansStroke VolumeEchocardiographyHealth related quality of lifeHeart failure with preserved ejection fractionSpironolactone

Identifiers

PMID35101539
PMCPMC12611552

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.